Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Ang JE"'
Autor:
Ang, JE, Pal, A, Asad, YJ, Henley, AT, Valenti, M, Box, G, de haven Brandon, A, Revell, Victoria, Skene, Debra, Venturi, M, Rueger, R, Meresse, V, Eccles, SA, de Bono, JS, Kaye, SB, Workman, P, Banerji, U, Raynaud, FI
MAPK pathway activation is frequently observed in human malignancies, including melanoma, and is associated with sensitivity to MEK inhibition and changes in cellular metabolism. Using quantitative mass spectrometry-based metabolomics, we identified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______305::68aab6af42953432ba15382da278000a
https://surrey.eprints-hosting.org/841474/
https://surrey.eprints-hosting.org/841474/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Clinical Oncology; 6/1/2009, Vol. 27 Issue 16, p2692-2696, 5p
Autor:
Finlay-Jones AL; Telethon Kids Institute, Nedlands, Western Australia; Curtin University, Bentley, Western Australia; University of Western Australia, Crawley, Western Australia. Electronic address: amy.finlay-jones@telethonkids.org.au., Ang JE; Telethon Kids Institute, Nedlands, Western Australia., Brook J; Telethon Kids Institute, Nedlands, Western Australia., Lucas JD; Telethon Kids Institute, Nedlands, Western Australia., MacNeill LA; Northwestern University, Chicago, Illinois., Mancini VO; Telethon Kids Institute, Nedlands, Western Australia., Kottampally K; Telethon Kids Institute, Nedlands, Western Australia., Elliott C; Telethon Kids Institute, Nedlands, Western Australia; Curtin University, Bentley, Western Australia., Smith JD; University of Utah, Salt Lake City, Utah., Wakschlag LS; Northwestern University, Chicago, Illinois.
Publikováno v:
Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2024 Feb; Vol. 63 (2), pp. 184-215. Date of Electronic Publication: 2023 Feb 28.
Autor:
Banerjee S; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Michalarea V; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Ang JE; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Ingles Garces A; Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Biondo A; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Funingana IG; Cambridge University Hospitals NHS Foundation Trust and University of Cambridge, Cambridge, United Kingdom., Little M; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, United Kingdom., Ruddle R; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Raynaud F; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Riisnaes R; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Gurel B; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Chua S; Radiology and Nuclear Medicine Department, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Tunariu N; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Radiology and Nuclear Medicine Department, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Porter JC; UCL Respiratory, University College London and Interstitial Lung Disease Service, University College London NHS Foundation Trust, London, United Kingdom., Prout T; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Parmar M; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Zachariou A; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Turner A; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Jenkins B; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., McIntosh S; Carrick Therapeutics, Dublin, Ireland., Ainscow E; Carrick Therapeutics, Dublin, Ireland., Minchom A; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Lopez J; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., de Bono J; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Jones R; Cardiff University, School of Medicine, Velindre University NHS Trust, Cardiff, United Kingdom., Hall E; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Cook N; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom., Basu B; Cambridge University Hospitals NHS Foundation Trust and University of Cambridge, Cambridge, United Kingdom., Banerji U; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Nov 01; Vol. 28 (21), pp. 4634-4641.
Autor:
Funingana IG; Department of Oncology, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Reinius MAV; Department of Oncology, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Petrillo A; Medical Oncology Unit, Ospedale del Mare, Naples, Italy; University of Study of Campania 'L.Vanvitelli', Naples, Italy. Electronic address: angelic.petrillo@gmail.com., Ang JE; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Brenton JD; Department of Oncology, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
Publikováno v:
Seminars in cancer biology [Semin Cancer Biol] 2021 Dec; Vol. 77, pp. 67-82. Date of Electronic Publication: 2021 Feb 16.
Autor:
Sahin H; Department of Radiology, School of Clinical Medicine, University of Cambridge, Cambridgeshire, Cambridge, CB2 0QQ, UK. hs705@cam.ac.uk.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK. hs705@cam.ac.uk., Panico C; General Diagnostic and Interventional Radiology, Diagnostic Imaging Area, Department of Diagnostic Imaging, Radiation Oncology and Hematology, Fondazione Policlinico Universitario 'A. Gemelli'-IRCCS, Universita Cattolicá del Sacro Cuore, Rome, Italy., Ursprung S; Department of Radiology, School of Clinical Medicine, University of Cambridge, Cambridgeshire, Cambridge, CB2 0QQ, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK., Simeon V; Medical Statistics Unit, Department of Mental, Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy., Chiodini P; Medical Statistics Unit, Department of Mental, Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy., Frary A; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK., Carmo B; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK., Smith J; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK., Freeman S; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK., Jimenez-Linan M; Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK., Bolton H; Gynaecological Oncology, Addenbrooke's Hospital, Cambridge, UK.; SGRN, Surgical Gynaecological Oncology Research Network, UK., Haldar K; Gynaecological Oncology, Addenbrooke's Hospital, Cambridge, UK., Ang JE; Department of Oncology, Addenbrooke's Hospital, Cambridge, UK., Reinhold C; Department of Medical Imaging, McGill University Health Centre (MUHC), Montreal, Quebec, Canada.; Augmented Intelligence Precision Laboratory (AIPHL), McGill University Health Centre Research Institute, Montreal, Quebec, Canada., Sala E; Department of Radiology, School of Clinical Medicine, University of Cambridge, Cambridgeshire, Cambridge, CB2 0QQ, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK., Addley H; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK.; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
Publikováno v:
European radiology [Eur Radiol] 2021 Sep; Vol. 31 (9), pp. 6962-6973. Date of Electronic Publication: 2021 Mar 16.
Autor:
Finlay-Jones A; Early Neurodevelopment and Mental Health, Telethon Kids Institute, Nedlands, Western Australia, Australia amy.finlay-jones@telethonkids.org.au.; School of Population Health, Curtin University, Bentley, Western Australia, Australia., Ang JE; Early Neurodevelopment and Mental Health, Telethon Kids Institute, Nedlands, Western Australia, Australia., Bennett E; School of Nursing & Midwifery, The University of Notre Dame Australia, Fremantle, Western Australia, Australia.; Ngangk Yira Research Centre for Aboriginal Health and Social Equity, Murdoch University, Murdoch, Western Australia, Australia., Downs J; School of Physiotherapy and Exercise Science, Curtin University, Perth, Western Australia, Australia.; Child Disability, Telethon Kids Institute, Nedlands, Western Australia, Australia., Kendall S; Centre for Health Services Studies, University of Kent, Canterbury, UK., Kottampally K; Early Neurodevelopment and Mental Health, Telethon Kids Institute, Nedlands, Western Australia, Australia.; School of Psychological Sciences, The University of Western Australia, Crawley, Western Australia, Australia., Krogh-Jespersen S; Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Institute for Innovations in Developmental Sciences, Northwestern University, Chicago, Illinois, USA., Lim YH; Early Neurodevelopment and Mental Health, Telethon Kids Institute, Nedlands, Western Australia, Australia., MacNeill LA; Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Institute for Innovations in Developmental Sciences, Northwestern University, Chicago, Illinois, USA., Mancini V; Early Neurodevelopment and Mental Health, Telethon Kids Institute, Nedlands, Western Australia, Australia.; School of Population Health, Curtin University, Bentley, Western Australia, Australia., Marriott R; Ngangk Yira Research Centre for Aboriginal Health and Social Equity, Murdoch University, Murdoch, Western Australia, Australia., Milroy H; Youth Mental Health, Telethon Kids Institute, Nedlands, Western Australia, Australia.; Department of Psychiatry, School of Medicine, University of Western Australia, Crawley, Western Australia, Australia., Robinson M; Youth Mental Health, Telethon Kids Institute, Nedlands, Western Australia, Australia., Smith JD; Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; School of Medicine, The University of Utah, Salt Lake City, Utah, USA., Wakschlag LS; Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Institute for Innovations in Developmental Sciences, Northwestern University, Chicago, Illinois, USA., Ohan JL; School of Psychological Sciences, The University of Western Australia, Crawley, Western Australia, Australia.
Publikováno v:
BMJ open [BMJ Open] 2021 Jun 10; Vol. 11 (6), pp. e046078. Date of Electronic Publication: 2021 Jun 10.
Autor:
Beer L; Department of Radiology, University of Cambridge, Cambridge, CB2 0QQ, UK.; Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, 1090, Vienna, Austria.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK., Martin-Gonzalez P; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK., Delgado-Ortet M; Department of Radiology, University of Cambridge, Cambridge, CB2 0QQ, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK., Reinius M; Department of Radiology, University of Cambridge, Cambridge, CB2 0QQ, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK., Rundo L; Department of Radiology, University of Cambridge, Cambridge, CB2 0QQ, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK., Woitek R; Department of Radiology, University of Cambridge, Cambridge, CB2 0QQ, UK.; Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, 1090, Vienna, Austria.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK., Ursprung S; Department of Radiology, University of Cambridge, Cambridge, CB2 0QQ, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK., Escudero L; Department of Radiology, University of Cambridge, Cambridge, CB2 0QQ, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK., Sahin H; Department of Radiology, University of Cambridge, Cambridge, CB2 0QQ, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK., Funingana IG; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK., Ang JE; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK.; Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK., Jimenez-Linan M; Department of Pathology, Addenbrooke's Hospital, Cambridge, UK., Lawton T; Canon Medical Research Europe Ltd, Edinburgh, UK., Phadke G; Canon Medical Research Europe Ltd, Edinburgh, UK., Davey S; Canon Medical Systems LTD, Crawley, UK., Nguyen NQ; Information Engineering Division, Department of Engineering, University of Cambridge, Cambridge, CB2 1PZ, UK., Markowetz F; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK., Brenton JD; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK., Crispin-Ortuzar M; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK., Addley H; Department of Radiology, University of Cambridge, Cambridge, CB2 0QQ, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK.; Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK., Sala E; Department of Radiology, University of Cambridge, Cambridge, CB2 0QQ, UK. es220@medschl.cam.ac.uk.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, CB2 0RE, UK. es220@medschl.cam.ac.uk.
Publikováno v:
European radiology [Eur Radiol] 2021 Jun; Vol. 31 (6), pp. 3765-3772. Date of Electronic Publication: 2020 Dec 14.
Autor:
Terbuch A; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom.; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Tiu C; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom., Candilejo IM; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom.; Division of Medical Oncology, START Madrid-HM Sanchinarro CIOCC Early Phase Program, Medical University Hospital of Sanchinarro, Madrid, Spain., Scaranti M; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom., Curcean A; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom., Bar D; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom., Estevez Timon M; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom., Ameratunga M; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom.; Monash University, Melbourne, Australia., Ang JE; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom.; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Ratoff J; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom.; Epsom and St. Helier University Hospitals NHS Trust, Epsom, United Kingdom., Minchom AR; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom., Banerji U; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom., de Bono JS; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom., Tunariu N; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom., Lopez JS; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom. juanita.lopez@icr.ac.uk.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Sep 15; Vol. 26 (18), pp. 4805-4813. Date of Electronic Publication: 2020 Apr 24.